I-Mab Biopharma
IMAB
#9317
Rank
HK$0.51 B
Marketcap
HK$6.29
Share price
-5.65%
Change (1 day)
-55.38%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -HK$1.56 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are HK$3.27 Million. a decrease over its 2023 earnings that were of -HK$52.43 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.39 Billion642.25%
2023 -HK$52.43 Million-11.48%
2022-HK$59.22 Million-86.72%
2021-HK$0.45 Billion-605.96%
2020 HK$88.13 M-138.32%
2019 -HK$0.23 Billion260.14%
2018 -HK$63.87 Million19.49%
2017-HK$53.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.15 Billion-90.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$80.4 Million-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA